bvs857
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01435330)
Timeline
Indications
Mechanism of action
IGF1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bvs857
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02024932 | Phase 2 | Feb 1, 2014 | Novartis |
| NCT02074995 | Phase 2 | Feb 1, 2014 | Novartis |
| NCT01435330 | Phase 1 | Mar 1, 2011 | Novartis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 3 | 3 | 2 | 2011 |
1 organizations
Page 1 / 1